Lumens Bios루멘스바이오스
038060 · KOSDAQ · ₩038060 · 루멘스바이오스
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩1,800
vs the current price (₩1,001)
- Enterprise value
- −₩34B
- Equity value
- ₩47B
- WACC
- 7.4%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model is 80% away from today's price. A gap this size usually means the market expects something the past figures don't show yet, or the model leaves something out. What we can see:
- To match today's price of ₩1,001, the model needs an operating margin of −1.6% every year (it uses −0.7%).
- In the projection, spending on equipment, software and working capital takes most or all of the after-tax operating profit, so free cash flow is thin. Companies that invest heavily often look like this until spending slows.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- ₩950
- −5.1%
- Base
- ₩1,800
- +79.8%
- Bull
- ₩3,621
- +261.8%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (−0.7%).
Revenue growth
- 1.8%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (1.8% a year, annual reports), fading to 3% by year 5.
- 2.1%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (1.8% a year, annual reports), fading to 3% by year 5.
- 2.4%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (1.8% a year, annual reports), fading to 3% by year 5.
- 2.7%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (1.8% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (1.8% a year, annual reports), fading to 3% by year 5.
Business
- -0.7%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 1.7%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 2.1%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- 16.9%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.11%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-28.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta -0.1, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.61%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩164B
- Net debt (borrowings and leases − cash and deposits)
- −₩62B
- + Stakes and investments
- ₩18B
- Associates, long-term financial assets and deposits (book value)
- Shares
- 25,837,248
- Share price
- ₩1,001
- Market cap
- ₩26B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩171B | ₩174B | ₩176B | ₩167B | ₩170B | ₩174B | ₩179B | ₩184B |
| Growth | 3.0% | 1.7% | 0.8% | 1.8% | 2.1% | 2.4% | 2.7% | 3.0% |
| EBIT | ₩2.7B | −₩1.6B | −₩5B | −₩1.2B | −₩1.2B | −₩1.2B | −₩1.3B | −₩1.3B |
| EBIT margin | 1.6% | −0.9% | −2.9% | −0.7% | −0.7% | −0.7% | −0.7% | −0.7% |
| After-tax EBIT | ₩2B | −₩1.2B | −₩3.6B | −₩846M | −₩864M | −₩885M | −₩909M | −₩936M |
| + Depreciation | — | — | — | ₩2.8B | ₩2.9B | ₩3B | ₩3B | ₩3.1B |
| − Capital spending | ₩5.3B | ₩2.7B | ₩2.7B | ₩3.5B | ₩3.6B | ₩3.7B | ₩3.8B | ₩3.9B |
| − Working capital | −₩27B | ₩13B | −₩15B | ₩498M | ₩592M | ₩691M | ₩796M | ₩908M |
| Free cash flow | — | — | — | −₩2B | −₩2.1B | −₩2.3B | −₩2.4B | −₩2.6B |
| Discount factor | — | — | — | 0.931 | 0.867 | 0.807 | 0.751 | 0.700 |
| Present value | — | — | — | −₩1.9B | −₩1.9B | −₩1.8B | −₩1.8B | −₩1.8B |
Terminal value −₩35B, worth −₩25B today: 73% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩4,250 a share)Now 0.24× | ₩1,4670.35× | ₩2,4010.57× | ₩3,3340.78× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.4% | ₩1,919 | ₩1,739 | ₩1,517 | ₩1,237 | ₩873 |
| 6.9% | ₩2,012 | ₩1,858 | ₩1,673 | ₩1,444 | ₩1,156 |
| 7.4% | ₩2,090 | ₩1,958 | ₩1,800 | ₩1,609 | ₩1,374 |
| 7.9% | ₩2,158 | ₩2,042 | ₩1,906 | ₩1,744 | ₩1,549 |
| 8.4% | ₩2,216 | ₩2,114 | ₩1,996 | ₩1,856 | ₩1,691 |
Now (TTM)
- Market cap
- ₩26B
- Enterprise value
- −₩37B
- P/E
- —
- P/B
- 0.2×
- P/S
- 0.2×
- EV/EBITDA
- —
- Dividend yield
- 0.0%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Price | ₩1,226 | ₩2,134 | ₩2,586 | ₩2,040 | ₩2,420 |
| Market cap | ₩32B | ₩55B | ₩67B | ₩53B | ₩63B |
| P/E | — | 6.2× | 16.7× | 3.3× | — |
| P/B | 0.3× | 0.5× | 0.7× | 0.6× | 0.8× |
| P/S | 0.2× | 0.3× | 0.4× | 0.3× | 0.4× |
| EV/EBITDA | — | — | — | — | — |
| Dividend yield | 0.0% | — | — | — | — |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| Lumens Bios | — | 0.2× | 0.2× | — | 0.0% |
| SK hynix | 6.0× | 3.7× | 5.2× | — | 0.2% |
| DB HiTek | 11.9× | 1.7× | 2.7× | — | 0.9% |
| Fadu | — | 37.7× | 13.2× | — | 0.0% |
| Hana Micron | 13.8× | 4.3× | 1.1× | — | 0.2% |
| Jeju Semiconductor | 9.5× | 4.9× | 3.3× | — | 0.0% |
| SFA Semicon | — | 3.0× | 3.2× | — | 0.0% |
| Similar companies (median) | 10.7× | 4.0× | 3.2× | — | 0.1% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: Lumens Bios / 루멘스바이오스 / 038060 / KRX:038060
Source: KRX statistical information